NexGel Inc (NXGL)
2.60
+0.06
(+2.56%)
USD |
NASDAQ |
Sep 20, 16:00
2.60
0.00 (0.00%)
After-Hours: 20:00
NexGel Cash from Operations (TTM): -3.102M for June 30, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
June 30, 2024 | -3.102M |
March 31, 2024 | -3.619M |
December 31, 2023 | -3.236M |
September 30, 2023 | -3.298M |
June 30, 2023 | -3.423M |
March 31, 2023 | -2.904M |
December 31, 2022 | -2.992M |
September 30, 2022 | -3.54M |
June 30, 2022 | -3.215M |
March 31, 2022 | -3.205M |
Date | Value |
---|---|
December 31, 2021 | -2.753M |
September 30, 2021 | -1.979M |
June 30, 2021 | -1.854M |
March 31, 2021 | -1.486M |
December 31, 2020 | -1.801M |
September 30, 2020 | -1.765M |
June 30, 2020 | -1.635M |
March 31, 2020 | -1.918M |
December 31, 2019 | -1.814M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-3.619M
Minimum
Mar 2024
-1.486M
Maximum
Mar 2021
-2.607M
Average
-2.904M
Median
Mar 2023
Cash from Operations (TTM) Benchmarks
The Cooper Companies Inc | 615.40M |
Staar Surgical Co | 37.26M |
OrthoPediatrics Corp | -28.99M |
Innovative Eyewear Inc | -6.077M |
Perspective Therapeutics Inc | -14.17M |